Aducanumab Approval Decision Delayed: Could This Be Good News?

Amendment Triggered Three-Month Review Extension

 
• By Mandy Jackson
  
LED Display - Airport flight status board
The FDA requested more information on aducanumab and then delayed its approval decision until 7 June • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip